tiprankstipranks
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
US Market

Iovance Biotherapeutics (IOVA) Income Statement

Compare
3,224 Followers

Iovance Biotherapeutics Income Statement

Last quarter (Q4 2024), Iovance Biotherapeutics's total revenue was $73.69M, an increase of 15189.21% from the same quarter last year. In Q4, Iovance Biotherapeutics's net income was $-78.56M. See Iovance Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 164.07M$ 1.19M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 40.08M$ -9.57M$ -21.14M$ -13.98M$ -8.71M
Operating Expenses
$ 435.35M$ 450.99M$ 398.88M$ 342.70M$ 261.94M
Depreciation and Amortization
$ 0.00$ 33.13M$ 21.14M$ 13.98M$ 8.71M
EBITDA
$ -395.28M$ -427.43M$ -374.76M$ -328.27M$ -250.87M
Operating Income
$ -395.28M$ -460.56M$ -398.88M$ -342.70M$ -261.94M
Other Income/Expenses
$ 20.27M$ 13.04M$ 2.98M$ 451.00K$ 2.36M
Pretax Income
$ -375.00M$ -447.52M$ -395.89M$ -342.25M$ -259.58M
Net Income
$ -372.18M$ -444.04M$ -389.92M$ -327.82M$ -257.23M
Per Share Metrics
Basic EPS
$ -1.28$ -1.89$ -2.45$ -2.14$ -1.86
Diluted EPS
$ -1.28$ -1.89$ -2.45$ -2.14$ -1.86
Weighted Average Shares Outstanding
289.88M 235.13M 159.26M 153.41M 138.30M
Weighted Average Shares Outstanding (Diluted)
289.88M 235.13M 159.26M 153.41M 138.30M
Currency in USD

Iovance Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis